Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

How Synagis can help?

April 26, 2017Genesis help Home Management palivizumab program respiratory syncytial virus RSV synagis

0

Posted

How Synagis can help?

1 Answer

0

Posted

Synagis (palivizumab) is the first monoclonal antibody successfully developed to combat this infectious disease. It is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high-risk of RSV disease. Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and infants with a history of prematurity (less than 35 weeks gestational age). Synagis is approved by the FDA. Synagis is administered as a monthly intramuscular (IM) injection during the RSV season, typically fall through spring, however, the season varies and Genesis At Home is prepared to meet your needs.